CATALYST PHARMACEUTICALS, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

CATALYST PHARMACEUTICALS, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $588.99 million for the year ending 2025.

  • CATALYST PHARMACEUTICALS, INC. showed an increase of +19.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), CATALYST PHARMACEUTICALS, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 475.7%.
  • Historical annual values: Fiscal year 2025: $588.99 million | Fiscal year 2024: $491.73 million | Fiscal year 2023: $398.20 million | Fiscal year 2022: $214.20 million | Fiscal year 2021: $140.83 million | Fiscal year 2020: $119.07 million | Fiscal year 2019: $102.31 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: